Gelsomino, F <br/><br/>
Programmed death-1 inhibition and atherosclerosis: can nivolumab vanish complicated atheromatous plaques?  [electronic resource] 

 -  Annals of oncology : official journal of the European Society for Medical Oncology  01 2018 
 - 284-286 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1569-8041 
<br/><br/><label>Standard No.: </label>10.1093/annonc/mdx718  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Atherosclerosis--drug therapy<br/>Humans<br/>Nivolumab--therapeutic use<br/>Plaque, Atherosclerotic--drug therapy<br/>Programmed Cell Death 1 Receptor--antagonists & inhibitors